HC Wainwright Issues Positive Forecast for Tourmaline Bio (NASDAQ:TRML) Stock Price
Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of 165.96% from the stock’s current price. […]
Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of 165.96% from the stock’s current price. […]
-logo-1200x675.png?v=20240417094222&w=240&h=240&zc=2){kind=logo}
